Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Michel

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
European Journal of Immunology|October 10, 2001
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO miceH Firat, S Tourdot, A Ureta-Vidal, et al.
Gut|February 22, 2014
Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADNH Fontaine, S Kahi, C Chazallon, et al.
Microbiome|April 22, 2024
Dissecting the respective roles of microbiota and host genetics in the susceptibility of Card9<sup>-/-</sup> mice to colitisC Danne, B Lamas, A Lavelle, et al.
European Journal of Immunology|October 30, 1999
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategiesH Firat, F Garcia-Pons, S Tourdot, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
European Journal of Immunology|October 10, 2001
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO miceH Firat, S Tourdot, A Ureta-Vidal, et al.
Gut|February 22, 2014
Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADNH Fontaine, S Kahi, C Chazallon, et al.
Microbiome|April 22, 2024
Dissecting the respective roles of microbiota and host genetics in the susceptibility of Card9<sup>-/-</sup> mice to colitisC Danne, B Lamas, A Lavelle, et al.
European Journal of Immunology|October 30, 1999
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategiesH Firat, F Garcia-Pons, S Tourdot, et al.
Pageof 6